Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
146,160.000000 Euro
Forbid offers above base price:
Request Reference:
PH-111014923
Request Name:
AQUISICAO DE MEDICAMENTOS PHARMAKERN PORTUGAL - Produtos Farmacêuticos, Lda.
Phase:
Tendering Phase
State:
Awarded
Description:
AQUISICAO DE MEDICAMENTOS PHARMAKERN PORTUGAL - Produtos Farmacêuticos, Lda.
Procedure Type:
VortalGOV - Direct Award (ECP)
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Estrada do Forte do Alto do Duque 1449-005 Lisboa PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
9/26/2023 12:13 AM
(UTC +1 hour)
Due datetime for receiving replies:
9/26/2023 5:00 PM
(UTC +1 hour)
Financial Settings
Financial Settings
Define Advance Payments?
No
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
Anexo II.xlsx
Anexo II.xlsx
Download
Caderno de Encargos 111014923- pharmake.pdf
Caderno de Encargos 111014923- pharmake.pdf
Download
Convite 111014923 pharmaken.pdf
Convite 111014923 pharmaken.pdf
Download
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
1
Questionário
1.1
Main Section
1.1.1
Articulado
*
(Os valores indicados não incluem o IVA)
Solicitou requisitos adicionais nesta lista de preços.
Preço Total
Total without VAT
0,000000
EUR
Cód. Artigo
Referência Interna
Descrição
Qt
Unidade
Preço Unitário
Preço Total
Reference
1
Description
AQUISICAO DE MEDICAMENTOS PHARMAKERN PORTUGAL - Produtos Farmacêuticos, Lda.
Reference
1
Internal Reference
Description
INFLiximab (REMSIMA) 100 MG PO CONC SOL INJ FR IV
Qty
1 200,000000
Unit
FR
Price per Unit
Total
Reference
2
Internal Reference
Description
RITUximab (TRUXIMA) 500 MG/50 ML SOL INJ FR 50 ML IV
Qty
200,000000
Unit
FR
Price per Unit
Total
Reference
3
Internal Reference
Description
RITUximab (TRUXIMA) 100 MG/10 ML SOL INJ FR 10 ML IV
Qty
50,000000
Unit
FR
Price per Unit
Total
Reference
4
Internal Reference
Description
TRASTUzumab (HERZUMA) 150 MG PO CONC SOL INJ FR IV
Qty
50,000000
Unit
FR
Price per Unit
Total
Evaluation
Evaluation
Evaluation General Settings
Evaluation General Settings
Evaluation guideline
MostEconomicallyAdvantageousTender
Evaluation Method
Manual
Evaluation Items
Evaluation Items
Name
Lot
Critérios De Avaliação
Critérios de Adjudicação
Peso (%)**
1
Preço
100
Define tie breaking rules?
Yes
No
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...